Cascade Investment Advisors, Inc. Amgen Inc Transaction History

Cascade Investment Advisors, Inc.

$156 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $69,994 - $85,312	-310 Reduced 4.27%	6,948 $1.68 Million
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $19,467 - $24,735	-85 Reduced 1.16%	7,258 $0
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $213,237 - $240,492	-950 Reduced 11.46%	7,343 $1.99 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $199,102 - $221,566	-863 Reduced 9.43%	8,293 $2.02 Billion
Q1 2022 Apr 11, 2022	BUY	$219.27 - $242.57 $16,006 - $17,707	73 Added 0.8%	9,156 $2.21 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $54,095 - $61,907	272 Added 3.09%	9,083 $2.04 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $188,920 - $221,343	890 Added 11.24%	8,811 $1.87 Billion
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $9,343 - $10,365	40 Added 0.51%	7,921 $1.93 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $6,657 - $7,758	30 Added 0.38%	7,881 $1.96 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $27,047 - $32,208	125 Added 1.62%	7,851 $1.81 Billion
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $24,403 - $27,138	-104 Reduced 1.33%	7,726 $1.96 Billion
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $31,649 - $38,838	-160 Reduced 2.0%	7,830 $1.85 Billion
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $49,204 - $65,259	-270 Reduced 3.27%	7,990 $1.62 Billion
Q4 2019 Jan 22, 2020	SELL	$189.21 - $243.2 $64,331 - $82,688	-340 Reduced 3.95%	8,260 $1.99 Billion
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $49,621 - $59,456	285 Added 3.43%	8,600 $1.66 Billion
Q2 2019 Jul 18, 2019	BUY	$166.7 - $195.41 $202,540 - $237,423	1,215 Added 17.11%	8,315 $1.53 Billion
Q1 2019 Apr 15, 2019	BUY	$180.87 - $203.88 $13,565 - $15,291	75 Added 1.07%	7,100 $1.35 Billion
Q4 2018 Jan 25, 2019	BUY	$178.4 - $208.25 $31,220 - $36,443	175 Added 2.55%	7,025 $1.37 Billion
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $15,749 - $17,755	-85 Reduced 1.23%	6,850 $1.42 Billion
Q2 2018 Jul 31, 2018	SELL	$166.05 - $186.51 $175,182 - $196,768	-1,055 Reduced 13.2%	6,935 $1.28 Billion
Q1 2018 Apr 23, 2018	BUY	$169.43 - $198.0 $7,624 - $8,910	45 Added 0.57%	7,990 $1.36 Billion
Q4 2017 Jan 17, 2018	SELL	$168.79 - $188.59 $16,879 - $18,859	-100 Reduced 1.24%	7,945 $1.38 Billion
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $1.35 Million - $1.54 Million	8,045	8,045 $1.5 Billion

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.

Account